Skip to content

Bausch Health Companies BHC Solta Medical — Goodwill, impairment loss

Other segment segments

Salix
$1.43B
Bausch + Lomb
$0
Diversified
$0-100%
International
$0

Similar metrics at other companies

Novanta logo
NOVTMedical Solutions — Goodwill Impaired Accumulated Impairment Loss
$31.72M0.0%
Novanta logo
NOVTMedical Solutions — Goodwill
$316.9M+14.8%
MKS Instruments logo
MKSIMaterials Solutions Division — Goodwill Impairment
$0
CSW Industrials, Inc. logo
CSWSpecialized Reliability Solutions — Goodwill, Impairment Loss
$0
Cardinal Health logo
CAHPharmaceutical and Specialty Solutions — Goodwill, Impairment Loss
$184M
DENTSPLY SIRONA logo
XRAYWellspect Healthcare — Goodwill, Impairment Loss
$0

Other financials

Income statement

See full
Revenue$2.5B+11.7%
Operating income-$950.0M-444%
Net income-$1.4B-2,353%
EPS (diluted)-$3.82-2,287%

Balance sheet

See full
Cash & equivalents$1.3B+13.4%
Total debt$20.8B-3.5%
Total equity-$2.1B-74.0%
Total assets$24.5B-7.3%

Cash flow

See full
Operating cash flow$230.0M+9.0%
CapEx$109.0M-5.2%
Free cash flow$121.0M+26.0%

Valuation

See full
Market cap$1.86B-15.9%

Profitability

See full
Gross margin71.4%
Operating margin5.6%-10.3pp
Net margin-1.9%-0.9pp
FCF margin9.8%-2.8pp

Returns & leverage

See full
Return on equity-70.1%
Debt / equity45.2×
Current ratio1.3×0.0×

Where this comes from

Reported directly by Bausch Health Companies in its filing.

Tagged under the XBRL concept us-gaap:GoodwillImpairmentLoss.

The official record: Bausch Health Companies’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Bausch Health Companies's solta medical — goodwill, impairment loss.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Bausch Health Companies's solta medical — goodwill, impairment loss?
Bausch Health Companies (BHC) reported solta medical — goodwill, impairment loss of $0 in Q1 2026.
What does solta medical — goodwill, impairment loss mean?
Measures the reduction in the carrying value of goodwill for the Solta Medical segment when the recorded asset value exceeds its implied fair value. This charge indicates a decline in the expected future economic benefits of the segment's acquired businesses.